ARB
Clinical trials for ARB explained in plain language.
Never miss a new study
Get alerted when new ARB trials appear
Sign up with your email to follow new studies for ARB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy injection aims to halt rare blindness
Disease control Recruiting nowThis early-stage trial tests a gene therapy called OPGx-BEST1 for two rare inherited eye diseases that cause vision loss. About 10 adults will receive a single injection into one eye to see if it is safe and to find the best dose. The study will follow participants for 5 years to…
Matched conditions: ARB
Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Everyday drugs might tame COVID: 3,000-Patient trial launched
Knowledge-focused Recruiting nowThis study looks back at 3,000 hospital patients to see if those who got a flu shot, took blood pressure meds (ACEI/ARB), antihistamines, or amantadine had better COVID-19 outcomes. Researchers want to know if these common treatments can reduce deaths or shorten hospital stays. N…
Matched conditions: ARB
Sponsor: Consorci Sanitari de Terrassa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC